Nov 12, 2025

Featuring perspectives from Dr Emmanuel S Antonarakis and Dr Matthew R Smith, including the following topics: 

• Current and Future Role of Immune Checkpoint Inhibitors in the Management of Colorectal Cancer — Dr Lieu (0:00)
• Other Biomarker-Based Strategies for Patients with Colorectal Cancer — Dr Strickler (36:39)

Oct 30, 2025

Featuring an interview from Dr John Strickler, including the following topics:

• Prognostic value of molecular residual disease (MRD) as detected by circulating tumor DNA (ctDNA) and optimal incorporation of MRD assays into the care of patients with colorectal cancer (0:00)
• Potential use of MRD assays for patients with...

Oct 29, 2025

Featuring a slide presentation and related discussion from Dr John Strickler, including the following topics:

• Defining molecular residual disease (MRD); tumor-informed and tumor-naïve methods for assessing (0:00)
• GALAXY and BESPOKE CRC studies of a tumor-informed MRD assay to identify patients with localized...

Aug 28, 2025

Featuring perspectives from Dr Haley Ellis and Dr James J Harding, including the following topics: 

• Introduction: Is Biliary Tract Cancer (BTC) the New Non-Small Cell Lung Cancer? … Why? (0:00)
• Case: A woman in her mid 70s with metastatic cholangiocarcinoma receives first-line gemcitabine/cisplatin with durvalumab...

Jul 14, 2025

Featuring perspectives from Dr Haley Ellis, Dr Sara Lonardi and Dr Kanwal Raghav, moderated by Dr Christopher Lieu, including the following topics:

• Introduction (0:00)
• Gastroesophageal Cancers — Dr Lonardi (1:54)
• Biliary Tract Cancers — Dr Ellis (39:20)
• Colorectal Cancer — Dr Raghav (1:07:10)

CME information and...